Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
Parker
Chris
C
Graham
John
J
D019317:Evidence-Based Medicine / Q000592:standards*; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic / Q000592:standards*; D011471:Prostatic Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors